DK3694526T3 - Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler - Google Patents

Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler Download PDF

Info

Publication number
DK3694526T3
DK3694526T3 DK18865483.4T DK18865483T DK3694526T3 DK 3694526 T3 DK3694526 T3 DK 3694526T3 DK 18865483 T DK18865483 T DK 18865483T DK 3694526 T3 DK3694526 T3 DK 3694526T3
Authority
DK
Denmark
Prior art keywords
agnostic
genotype
rescue
bicarbonate
channels
Prior art date
Application number
DK18865483.4T
Other languages
Danish (da)
English (en)
Inventor
Martin D Burke
Katrina A Muraglia
Rajeev S Chorghade
Michael J Welsh
Original Assignee
Univ Illinois
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois, Univ Iowa Res Found filed Critical Univ Illinois
Application granted granted Critical
Publication of DK3694526T3 publication Critical patent/DK3694526T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18865483.4T 2017-10-11 2018-10-11 Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler DK3694526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762570795P 2017-10-11 2017-10-11
PCT/US2018/055435 WO2019075214A2 (en) 2017-10-11 2018-10-11 INDEPENDENT RESCUEING OF THE GENOTYPE OF CYSTIC FIBROSIS WITH BICARBONATE CHANNELS WITH SMALL MOLECULES

Publications (1)

Publication Number Publication Date
DK3694526T3 true DK3694526T3 (da) 2025-02-03

Family

ID=66100102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18865483.4T DK3694526T3 (da) 2017-10-11 2018-10-11 Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler

Country Status (10)

Country Link
US (3) US12090164B2 (enExample)
EP (1) EP3694526B1 (enExample)
JP (2) JP7355335B2 (enExample)
AU (2) AU2018348214C1 (enExample)
CA (1) CA3076246A1 (enExample)
DK (1) DK3694526T3 (enExample)
ES (1) ES3009563T3 (enExample)
FI (1) FI3694526T3 (enExample)
PT (1) PT3694526T (enExample)
WO (1) WO2019075214A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3694526T (pt) 2017-10-11 2025-01-20 Univ Illinois Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas
IL315719A (en) 2022-03-21 2024-11-01 Univ Illinois Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals
WO2025019806A2 (en) * 2023-07-19 2025-01-23 The Board Of Trustees Of The University Of Illinois Restoring physiology with small molecule mimics of missing proteins
EP4780466A1 (en) * 2023-09-20 2026-07-29 The Board Of Trustees Of The University Of Illinois Additive effects for molecular prosthetcs and cftr modulators in cf epithelia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
AU2003304204B2 (en) * 2002-10-29 2009-12-24 Insmed Incorporated Sustained release of antiinfectives
TWI249408B (en) 2003-12-10 2006-02-21 Ind Tech Res Inst New antifungal formulation and manufacturing method thereof
CN101014322A (zh) * 2004-06-11 2007-08-08 吉藤德拉·纳提·维玛 盐水中富含固醇的添加两性霉素的混合层状脂质体及其制备方法
US8507441B2 (en) 2009-10-22 2013-08-13 University of Pittsburgh—Of the Commonwealth Systems of Higher Education Use of endostatin peptides for the treatment of fibrosis
US8945605B2 (en) * 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
JP6796581B2 (ja) * 2014-11-04 2020-12-09 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois ミッシングタンパク質の小分子模倣体を用いた生理機能の回復
ES2983639T3 (es) 2016-04-08 2024-10-24 The Board Of Trustees Of The Univ Illinois Restauración mediada por moléculas pequeñas de la fisiología de la superficie de las vías respiratorias en epitelios pulmonares humanos de fibrosis quística
US10960018B2 (en) * 2016-04-15 2021-03-30 The Uab Research Foundation Methods and compounds for stimulating read-through of premature termination codons
PT3694526T (pt) 2017-10-11 2025-01-20 Univ Illinois Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas

Also Published As

Publication number Publication date
US20250000886A1 (en) 2025-01-02
WO2019075214A3 (en) 2020-04-02
ES3009563T3 (en) 2025-03-27
JP7355335B2 (ja) 2023-10-03
CA3076246A1 (en) 2019-04-18
FI3694526T3 (fi) 2025-02-06
US20250009775A1 (en) 2025-01-09
JP2020536859A (ja) 2020-12-17
AU2018348214B2 (en) 2024-08-08
EP3694526A4 (en) 2021-06-09
JP2023126932A (ja) 2023-09-12
EP3694526A2 (en) 2020-08-19
US12090164B2 (en) 2024-09-17
US20200352970A1 (en) 2020-11-12
AU2024259758A1 (en) 2024-11-21
AU2018348214C1 (en) 2025-01-30
AU2018348214A1 (en) 2020-04-23
EP3694526B1 (en) 2024-12-04
WO2019075214A2 (en) 2019-04-18
PT3694526T (pt) 2025-01-20

Similar Documents

Publication Publication Date Title
IL261987B (en) Modulators of cystic fibrosis transmembrane conductance regulator
EP3351144A4 (en) HOLLOW DESK PLATE
IL253661A0 (en) Sulfonylureas and related compounds and use of same
DK3554240T3 (da) Kombinationer af aktive forbindelser
EP3420388A4 (en) PUPILS EQUALIZATION
DK3280799T3 (da) Produktion af adeno-associerede vektorer i stor størrelse
MA54649A (fr) Modulateurs de régulateur de conductance transmembranaire de la fibrose kystique
DK3316747T3 (da) Opskumningsstav
DK3457851T3 (da) Derivater af sobetirom
EP3406336A4 (en) NANO FOIL OF CORE CASE STRUCTURE TYPE
IL242971A0 (en) Ventricular far field reduction
DK3294893T3 (da) Bioproduktion af lentivirale vektorer
EP3409338C0 (en) CONSTRUCTION GAME
EP3709676C0 (en) HEARING AID DEVICE COMPRISING A REMOVABLE SPEAKER UNIT
DK3474822T3 (da) Formuleringer af brincidofovir
EP3475083C0 (en) HOLLOW PANEL
EP3639067C0 (en) NEW LIGHTWEIGHT HOLLOW LENS STRUCTURE
EP3476452A4 (en) TOY WITH EJECTABLE TOP
EP3315131A4 (en) THERAPEUTICS FOR FIBROSIS
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
EP3394360C0 (en) ACOUSTIC WALL PANEL
PT3694526T (pt) Resgate independente do genótipo da fibrose quística com canais de bicarbonato de moléculas pequenas
EP3383950A4 (en) HIGHLY POROUS MICROCELLULAR POLYETHYLENE
DK3472314T3 (da) Fremstilling af faktor-xa-derivater
DK3430004T3 (da) Faststofformer af nilotinibsalte